The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab
暂无分享,去创建一个
R. Greil | S. Roesch | D. Neureiter | T. Melchardt | G. Rinnerthaler | E. Klieser | A. Egle | A. Gaggl | C. Hufnagl | L. Weiss | T. Magnes | C. Mittermair | Eckhard Klieser